Bio-Rad Laboratories Inc (NYSE:BIO) presented its fourth quarter and full-year 2025 financial results on February 12, 2026, revealing modest overall growth driven primarily by its Clinical Diagnostics ...

Healthpeak reported third-quarter earnings that were slightly ahead of our expectations, leading us to reaffirm our $36 per share fair value estimate for the no-moat firm. Same-store net operating ...

In today’s edition of our science segment Lab Rats, we look at the science behind athletics. In addition to all of the physical training that goes into an Olympic victory, what’s going on in an ...